Follicular lymphoma grade IIIb Save

Follicular Lymphoma Grade IIIb: Understanding the Aggressive Form of Follicular Lymphoma

Follicular Lymphoma is a type of non-Hodgkin's lymphoma that affects the lymphatic system. It is a slow-growing cancer that originates from the B-cells in the lymph nodes and bone marrow. Follicular Lymphoma Grade IIIb is a subtype of Follicular Lymphoma that is considered to be more aggressive than other subtypes.

Unlike other subtypes of Follicular Lymphoma, Grade IIIb is characterized by the presence of large cells in addition to the small lymphocytes. These large cells are known as centroblasts and are considered to be a hallmark of Grade IIIb. The presence of these large cells indicates that the cancer is more aggressive and requires more aggressive treatment.

Causes of Follicular Lymphoma Grade IIIb

The exact cause of Follicular Lymphoma is not known. However, certain risk factors have been identified that increase the likelihood of developing the disease. These risk factors include:

1. Age: Follicular Lymphoma is more common in people over the age of 60.
2. Gender: Men are slightly more likely to develop the disease than women.
3. Family history: A family history of lymphoma or other cancers increases the risk of developing Follicular Lymphoma.
4. Immune system disorders: People with weakened immune systems are at a higher risk of developing the disease.

Symptoms of Follicular Lymphoma Grade IIIb

The symptoms of Follicular Lymphoma Grade IIIb are similar to other subtypes of Follicular Lymphoma. These symptoms include:

• Enlarged lymph nodes
• Fever
• Night sweats
• Weight loss
• Fatigue
• Shortness of breath
• Abdominal pain or swelling
• Itchy skin

If you experience any of these symptoms, it is important to see your doctor for a proper diagnosis.

Treatment of Follicular Lymphoma Grade IIIb

The treatment of Follicular Lymphoma Grade IIIb depends on the stage of the cancer and the overall health of the patient. Treatment options may include:

• Chemotherapy
• Immunotherapy
• Radiation therapy
• Stem cell transplant
• Watchful waiting

Watchful waiting may be an option for patients with early